ArticleTherapeutic advances in medical oncology2022

Efficacy and safety of adding bevacizumab biosimilar or original drug to platinum-based chemotherapy as first-line treatment in patients with advanced NSCLC: a systematic review and meta-analysis.

Liu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.